WAVi
Private Company
Total funding raised: $5.9M
Overview
WAVi is a private, commercial-stage company offering a turnkey, FDA 510(k)-cleared EEG system for clinical use as an aid to diagnosis. Its core product, the WAVi Scan EEG system, combines a portable headset with proprietary software to deliver rapid (4-minute) evoked response tests and standard EEG readings, alongside integrated cognitive assessments. The company targets clinicians seeking objective neurological data to refine diagnoses, track intervention efficacy, and improve patient communication. WAVi operates on a hardware/software sales model with recurring revenue from disposable electrodes.
Technology Platform
Integrated FDA-cleared EEG hardware and software platform for rapid (4-minute) evoked response testing, standard EEG, and cognitive assessments. Features a portable 10-20 system headset, proprietary analysis software with customizable reports, and EDF export capability.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
WAVi competes in the digital EEG and brain health assessment market against traditional, complex EEG systems and a growing number of simplified, clinical-grade EEG devices. Its primary differentiators are its FDA clearance as an aid-to-diagnosis, rapid 4-minute evoked response test, and turnkey, clinician-friendly design aimed at non-specialists.